Heart failure and non-ST-segment elevation myocardial infarction: A review for a widespread situation

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 533-540

  Franco, E ^a   Nunez Gil I J ^a,b   Vivas, D ^a   Ruiz Mateos, B ^a   Ibanez B ^a,b   Gonzalo, N ^a   MacAya, C ^a   Fernandez Ortiz A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Heart failure; Myocardial infarction; NSTEMI; Prognostic; Review; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPLERENONE; ESMOLOL; FONDAPARINUX; GLYCERYL TRINITRATE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; HIRULOG; MORPHINE SULFATE; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; DEFIBRILLATOR; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPONATREMIA; HYPOTENSION; LOADING DRUG DOSE; MALE; MEDLINE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; SURVIVAL; THORAX PAIN;

EID: 80855130782     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.07.009     Document Type: Short Survey

References (67)

1. M.J. Wolk, S. Scheidt, and T. Killip Heart failure complicating acute myocardial infarction Circulation 45 5 1972 1125 1138
2. P.J. Nicod, E. Gilpin, and H. Dittrich Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction Am J Cardiol 61 1988 1165 1175
3. J.H. Lee, H.S. Park, and S.C. Chae Predictors of six-month major adverse events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry) Am J Cardiol 104 2 2009 182 189
4. W.J. Rogers, P.D. Frederick, and E. Stoehr Trends in presenting characteristics and hospital mortality amongst patients with ST elevation and non-ST elevation myocardial infarction from 1990 to 2006 Am Heart J 156 6 2008 1026 1034
5. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 23 2008 2909 2945
6. F.G. Kushner, M. Hand, and S.C. Smith 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
7. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society Eur Heart J 28 2007 1598 1660 (Pubitemid 47227122)
8. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 7 2007 e1 e157
9. A. Mostered, and A.W. Hoes Clinical epidemiology of heart failure Heart 93 2007 1137 1146 (Pubitemid 47311002)
10. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 19 2008 2388 2442
11. S. Stewart, A. Jenkins, and S. Buchan The current cost of heart failure to the National Health Service in the UK Eur J Heart Fail 4 2002 361 371 (Pubitemid 35190362)
12. M.R. Cowie, D.A. Wood, and A.J. Coats Survival of patients with a new diagnosis of heart failure: a population based study Heart 83 2000 505 510 (Pubitemid 30316712)
13. S. Stewart, K. MacIntyre, and D.J. Hole More "malignant" than cancer? Five-year survival following a first admission for heart failure Eur J Heart Fail 3 2001 315 322 (Pubitemid 32895839)
14. K.F. Fox, M.R. Cowie, and D.A. Wood Coronary artery disease as the cause of incident heart failure in the population Eur Heart J 22 2001 228 236 (Pubitemid 32622473)
15. M.S. Nieminen, D. Brutsaert, and K. Dickstein EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736 (Pubitemid 44729876)
16. F. Zannad, A. Mebazaa, and Y. Juilliere Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 2006 697 705 (Pubitemid 44754746)
17. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Failure National Registry (ADHERE) Am Heart J 149 2005 209 216 (Pubitemid 40348525)
18. G.C. Fonarow, W.T. Abraham, and N. Albert Impact of evidence-based heart failure therapy use at hospital discharge on treatment rates during follow-up: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 45 2005 345A
19. G.M. Felker, R.L. Benza, and A.B. Chandler Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 2003 997 1003 (Pubitemid 36315544)
20. I.J. Núñez-Gil, J.C. García-Rubira, and M. Luaces Mild heart failure is a mortality marker after a non ST-segment acute myocardial infarction Eur J Intern Med 21 5 2010 439 443
21. J.V. Wylie, S.A. Murphy, and D.A. Morrow Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 Am Heart J 148 1 2004 173 180 (Pubitemid 38900499)
22. A.S. Jaffe, J. Ravkilde, and R. Roberts It's time for a change to a troponin standard Circulation 102 2000 1216 1220
23. F.S. Apple, and A.H.B. Wu Myocardial infarction redefined: role of cardiac troponin testing Clin Chem 47 2001 377 379 (Pubitemid 32222449)
24. K.J. Mukamal, M.A. Mittleman, and M. Maclure Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction Am Heart J 137 1999 1120 1128 (Pubitemid 30040738)
25. A. Avezum, M. Makdisse, and F. Spencer for the GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary events (GRACE) Am Heart J 149 2005 67 73 (Pubitemid 40126492)
26. K. Thygesen, J.S. Alpert, and H.D. White On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
27. M. Gheorghiade, F. Zannad, and G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968 (Pubitemid 43739494)
28. M. Gheorghiade, W.T. Abraham, and N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226 (Pubitemid 44708052)
29. N. Beohar, A.K. Erdogan, and D.C. Lee Acute heart failure syndromes and coronary perfusion J Am Coll Cardiol 52 2008 13 16 (Pubitemid 351852938)
30. J.D. Flaherty, J.J. Bax, and L. De Luca Acute heart failure síndromes in patients with coronary artery disease. Early assessment and treatment J Am Coll Cardiol 59 3 2009 254 263
31. T. Killip III, and J.T. Kimball Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients Am J Cardiol 20 4 1967 457 464
32. V.S. DeGeare, J.A. Boura, and L.L. Grines Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 87 9 2001 1035 1038 (Pubitemid 32710315)
33. U.N. Khot, G. Jia, and D.J. Moliterno Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronay syndromes: the enduring value of Killip classification JAMA 290 16 2003 2174 2181 (Pubitemid 37432978)
34. H.K. Kim, M.H. Jeong, and Y. Ahn A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction Int J Cardiol 145 3 2010 450 454
35. B. Saejueng, T. Yipintsoi, and R. Chaisuksuwan Factors related to in-hospital heart failure are very different for unstable angina and non-ST elevation myocardial infarction Heart Vessels 24 6 2009 399 405
36. C.W. Yancy, M. Lopatin, and L.W. Stevenson Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84 (Pubitemid 43005168)
37. E.A. Amsterdam, J.D. Kirk, and D.A. Bluemke Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association Circulation 122 17 2010 1756 1776
38. T.H. Lee, and L. Goldman Evaluation of the patient with acute chest pain N Engl J Med 342 2000 1187 1195 (Pubitemid 30211051)
39. J.D. Flaherty, J.J. Bax, and L. De Luca Acute heart failure syndromes in patients with coronary artery disease J Am Coll Cardiol 53 2009 254 263
40. F. Follath, M.B. Yilmaz, and J.F. Delgado Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) Intensive Care Med 37 4 2011 619 626
41. J.L. Anderson, C.D. Adams, and E.M. Antman 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 18 2011 e426 e579
42. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
43. K.A. Fox, O.H. Dabbous, and R.J. Goldberg Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 2006 1091
44. C.B. Granger, R.J. Goldberg, and O. Dabbous Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353 (Pubitemid 37310196)
45. W.T. Abraham, K.F. Adams, and G.C. Fonarow In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64 (Pubitemid 40905130)
46. U. Elkayam, G. Tasissa, and C. Binanay Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 2007 98 104 (Pubitemid 44880871)
47. A. Mebazaa, J. Parissis, and R. Porcher Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods Intensive Care Med 37 2 2011 290 301
48. D. De Backer, P. Biston, and J. Devriendt Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 9 2010 779 789
49. J. Lopez-Sendon, K. Swedberg, and J. McMurray Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
50. Z.M. Chen, L.X. Jiang, and Y.P. Chen Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2006 1622 1632
51. M. Koutouzis, S. Nikolidakis, and A. Grigoriadis Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction Drugs Aging 23 8 2006 673 680 (Pubitemid 44394948)
52. M. Emery, J. López-Sendón, and P.G. Steg Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events Am Heart J 152 6 2006 Dec 1015 1021 (Pubitemid 44854809)
53. The Acute Infarction Ramipril Efficacy (AIRE) Study investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
54. M.A. Pfeffer, E. Braunwald, and L.A. Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
55. E. Braunwald, M.J. Domanski, and S.E. Fowler Angiotensin-converting enzyme inhibition in stable coronary artery disease N Engl J Med 351 2004 2058 2068
56. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events amongst patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
57. G.R. Dagenais, J. Pogue, and K. Fox Angiotensin-converting enzyme inhibitors in stable vascular disease without left ventricular dysfunction or heart failure: a combined analysis of three trials Lancet 368 2006 581 588 (Pubitemid 44209181)
58. N. Danchin, M. Cucherat, and C. Thuillez Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized trials Arch Intern Med 166 2006 787 796
59. K. Fox, R. Ferrari, and S. Yusuf Should angiotensin-converting enzyme inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function? Eur Heart J 27 2006 2154 2157 (Pubitemid 44412826)
60. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 14 2003 1309 1321 (Pubitemid 36384098)
61. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with left severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
62. F. Zannad, J.J. McMurray, and H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 1 2011 11 21
63. H. Boudrez, and G. De Backer Recent findings on return to work after acute myocardial infarction or coronary artery bypass grafting Acta Cardiol 55 2000 341 349 (Pubitemid 32147037)
64. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 2002 877 883 (Pubitemid 34984635)
65. P.E. Vardas, A. Auricchio, and J.J. Blanc Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace 9 2007 959 998
66. K. Dickstein, P.E. Vardas, and A. Auricchio Focused Update of ESC Guidelines on device therapy in heart failure. An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
67. A.S. Fein, Y. Wang, and J.P. Curtis Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 56 10 2010 766 773